BIOMARIN PHARMACEUTICAL INC·4

Mar 17, 8:48 PM ET

Davis George Eric 4

4 · BIOMARIN PHARMACEUTICAL INC · Filed Mar 17, 2026

Research Summary

AI-generated summary of this filing

Updated

BioMarin (BMRN) CLO George Davis Receives RSUs & Option Grant

What Happened

  • George Eric Davis, EVP and Chief Legal Officer of BioMarin (BMRN), was granted equity awards on March 16, 2026 and had shares withheld to cover tax obligations. He received 14,570 restricted stock units (RSUs) and a 34,690-share derivative option grant. To satisfy tax withholding, 7,177 shares were surrendered/withheld at $58.51 per share, totaling $419,926. The awards were granted (not open-market purchases or sales).

Key Details

  • Transaction date: 2026-03-16; filing date: 2026-03-17 (filed next day).
  • Tax withholding/disposition: 7,177 shares withheld at $58.51 each = $419,926.
  • Awards received: 14,570 RSUs (grant price not applicable) and 34,690-share option/derivative grant (no cash price).
  • Shares owned after transaction: not specified in the provided excerpt; the filing notes a clerical correction adjusting direct holdings by 13 shares (footnote F2).
  • Footnotes of note:
    • F1: RSUs granted March 16, 2026 (price not applicable).
    • F2: Direct holdings were adjusted by 13 shares to correct a clerical error.
    • F3: Option grant vesting: 12/48th on March 16, 2027, then 1/48th on the 16th of each month thereafter.
  • Timeliness: filing was made the next day (appears timely).

Context

  • The 7,177-share disposition is a tax withholding event (routine), not an open-market sale. The grants (RSUs and option) are compensation awards that vest over time; the option vests per the schedule in F3 and is not immediately fully exercisable. Awards like these are common for executives and reflect compensation rather than an investment purchase or sale decision.

Insider Transaction Report

Form 4
Period: 2026-03-16
Davis George Eric
EVP, Chief Legal Officer
Transactions
  • Tax Payment

    Common Stock

    2026-03-16$58.51/sh7,177$419,92665,263 total
  • Award

    Common Stock

    [F1][F2]
    2026-03-16+14,57079,833 total
  • Award

    Stock Option (Right to Buy Common Stock)

    [F3]
    2026-03-16+34,69034,690 total
    Exercise: $57.43From: 2027-03-17Exp: 2036-03-15Common Stock (34,690 underlying)
Footnotes (3)
  • [F1]Restricted stock units granted March 16, 2026. Price not applicable.
  • [F2]The Reporting Person's direct holdings have been adjusted by thirteen shares to correct a previous clerical error.
  • [F3]Option grant vests 12/48th on March 16, 2027 and 1/48th on the 16th day of each month thereafter.
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact|2026-03-17

Documents

1 file
  • 4
    wk-form4_1773794885.xmlPrimary

    FORM 4